Additionally, Isovalerylcarnitine (C5) levels diminish the protective role of CD62L- monocyte %monocyte against CRC, suggesting that retinol metabolism, lipid metabolism, and leucine metabolism in DC cells impact CRC progression. This evidence concerns the gene SELL and colorectal carcinoma.